|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����ʪ�� |
|
Th1/Th2ƽ�� |
|
��¡Ư�� |
| ��������������� | |
|
���������� |
|
��־����У |
|
Ǯ�����У |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
����ʪ�������ѧ��������
����������, ��־����У, Ǯ�����У
�㶫ҽѧԺƤ���Բ��о���
����ʪ���Th1��ϸ������ˮƽ�ձ齵��,Th2��ϸ������ˮƽ����ձ�����,Th1ϸ�����������,Th2ϸ������ǿ��,���߷�Ӧ�ɲ���������Th1�鵼��ϸ������Ӧ��������Th2��Ⱥϸ���鵼������Ӧ��,�Ӷ�������Ч����ϸ������Ӧ���������������ʪ������߷�Ӧ��Th2����Ư�ƿ�����������ͷ�����������������ݵ�һ�ֻ��ơ����ݻ���Thϸ��Ư��״��,�跨ʹ���߷�Ӧ��Th2����Th1����ת,����Th1/Th2ƽ��,�ݴ������Ӧ�����Ʒ���,�����ܸ����ٴ����Ƽ���ʪ�ࡣ
[2] Liu Y, Linsley PS. Costimulation of T cell growth. Curr Opin Immunol, 1992,4(3):265-270.
[3] Tendler Y, Schwartz Y, Reshef R, et al. Immunohistochemical detection of p53 protein expression in HPV-induced condyloma acuminatum. Acta Derm Venereol, 1995,75(3):177-179.
[4] Arany I, Tyring SK. Status of local celular immunity in interferon-responsive and nonresponsive human papillomavirus-associated lessions. Sex Transm Dis, 1996,23(6):475480.
[5] Arany I, Rady P, Zyring SK, et al. Effect of IFN therapy on HPV copy number in patients with condyloma acuminatum. Am J Med Sci, 1995,310(1):14-18.
[6] Arany I, Nagamam K, Tyring SK. Interferon resistance is independent from copy numbers in benign HPV-induced lesions. Anticancer Res,1995,15(3):1003-1006.
[7] Arany I, Goel A, Tyring SK. Interferon response depends on viral transcription in HPV-containing lessions. Anticancer Res, 1995, 15(6B):2865-2869.
[8] Kubin M, Chow JM, Trinchieri G. Differential regulation of IL-12, TNF�� and IL-I�� production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood, 1994,83(7):1847-1855.
[9] Wrenshall LE, Platt JL. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J Immunol, 1999,163(7):3793-3800.
[10] Cardamakis E, Kotoulas IG, Relakis K. Comparative study of systemic interferon-alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Urology, 1995,45(5):857-860.
[11] Carlson NG, Wieggel WA, Chen J, et al. Inflammatory cytokines IL-1��,IL-I��, IL-6 and TNF-�� impart neuroprotection to an excitotoxin through distinct pathways. J Immunol, 1999,163(7):3963-3968.
[12] Cohen MC, Cohen S. Cytokine function:a study in biologic diversity.Am J Clin Pathol, 1996, 105(5):589-598.
[13] Wynn TA, Morawetz R, Scharton-kersten T, et al. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1-and T helper cell 2-type cytokine respones in vivo. J Immunol, 1997, 159(10):5014-5023.
[14] Lasek W, Golab J, Maslinski W, et al. Subtherapeutic doses of IL-15 augment the antitumor effect of IL-12 in a B16F10 melanoma model in mice. Eur Cytokine Netw. 1999,10(3):345-356.
[15] Wu Q, Wang Y, Wang J, et al. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J Exp Med,1999,190(5):629-638.
[16] Tsujino S, Miyazaki T, Kawahara A, et al. Critical role of the membraneproximal, proline-rich motif of the IL-2 receptor gammac chain in the Jak3-independent signal transduction. Genes Cells, 1999,4(6):363-373.
[17] Abbas AK, Murphy KM, Sher A, et al. Functional diversity of helper T lymphocytes. Nature, 1996,383(6603):787-793.
[18] Gonrad CT, Ernst NR, Dummer W,et al. Differential expression of TGF-��,and IL-10 in progression and regressing areas of primary melanoma. J Exp Clin Cancer Res, 1999, 18(2):225-232.